Insider Shareholders with Direct Ownership of Nabriva Therapeutics PLC (NBRV)
This section provides a comprehensive overview of the insiders with direct ownership of Nabriva Therapeutics PLC (NBRV). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Nabriva Therapeutics plc Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Francesco Maria Lavino
Chief Commercial Officer |
0 | 366 | 185,393 $74,157 | 1 |
Sep 30, 2020
Reduced 0.2%
|
|
Robert Crotty
Gen Counsel & Corp Secretary |
22,500 | 2,750 | 41,194 $16,477 | 20 |
Aug 31, 2021
Reduced 0.09%
|
|
Jennifer Schranz
Chief Medical Officer |
22,500 | 1,002 | 39,125 $15,650 | 7 |
Feb 28, 2021
Reduced 0.08%
|
|
Colin Md Broom
Director |
17,500 | 5,870 | 36,523 $14,609 | 3 |
Aug 02, 2022
Reduced 12.75%
|
|
Gary Sender
Chief Financial Officer |
0 | 1,036 | 20,472 $8,188 | 6 |
Feb 28, 2021
Reduced 0.15%
|
|
Charles A Rowland Jr
Director |
17,500 | 9,273 | 15,277 $6,110 | 3 |
Aug 01, 2022
Reduced 35.74%
|
|
Steven P. Gelone
Director |
333,197 | 9,731 | 14,283 $5,713 | 56 |
Jan 29, 2023
Reduced 0.97%
|
|
Theodore R Schroeder
Director |
267,500 | 24,285 | 11,989 $4,795 | 57 |
Jan 29, 2023
Reduced 3.47%
|
|
Stephen W Webster
Director |
17,500 | 8,603 | 11,447 $4,578 | 3 |
Aug 02, 2022
Reduced 40.61%
|
|
Daniel D Burgess
Director |
17,500 | 12,466 | 10,384 $4,153 | 3 |
Aug 02, 2022
Reduced 52.2%
|
|
Carrie L. Bourdow
Director |
17,500 | 9,317 | 9,933 $3,973 | 3 |
Aug 01, 2022
Reduced 46.23%
|
|
Lisa Dalton
Director |
17,500 | 8,400 | 9,100 $3,640 | 2 |
Jul 31, 2022
Reduced 48.0%
|
|
Mark Corrigan
Director |
17,500 | 10,297 | 7,203 $2,881 | 2 |
Aug 02, 2022
Reduced 58.84%
|
|
J. Christopher Naftzger
General Counsel and Corp Sec |
7,000 | 0 | 7,000 $2,800 | 1 |
Dec 27, 2021
Added 50.0%
|